Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>BQE reported Q3 financial results yesterday that were mixed relative to our expectations, missing on revenue and beating on profitability.</li>
<li>Q3 proportional revenue came in at $10.7M (+12% YoY), below our estimate of $13.1M.</li>
<li>Adjusted EBITDA was $3.3M compared to our estimate of $3.0M.</li>
</ul>


BQE reported Q3 financial results yesterday that were mixed relative to our expectations, missing on revenue and beating on profitability.
Q3 proportional revenue came in at $10.7M (+12% YoY), below our estimate of $13.1M.
Adjusted EBITDA was $3.3M compared to our estimate of $3.0M.


BQE: Continuing to Generate Strong Cashflow

BQE Water

BQE: Continuing to Generate Strong Cashflow